Like many men and women who’ve had their lives upended by a cancer diagnosis, Atul Dhir found his journey with lymphoma to be deeply transformative, inspiring the arc of a career that has allowed him to help patients on many fronts—as a physician, a scientist and an innovator in the delivery of care and the development of anti-cancer drug therapies. A survivor of stage IV Hodgkin lymphoma (which later morphed into large-cell non-Hodgkin lymphoma), Dr. Dhir sits down with the host of Focus on Cancer, Cancer Treatment Centers of America® (CTCA) President & CEO Pat Basu, to share an insider’s look inside some innovations with the power to revolutionize the patient experience.